CNS depression potentiated with alcohol, other CNS depressants. Possible neurotoxicity with lithium: monitor, discontinue if occurs. Caution with drugs that prolong the QT interval (eg, ketoconazole, paroxetine). May be potentiated by CYP3A4 or CYP2D6 inhibitors/substrates (eg, itraconazole, nefazodone, buspirone, venlafaxine, alprazolam, fluvoxamine, quinidine, fluoxetine, sertraline, chlorpromazine, promethazine. May be antagonized by CYP3A4 inducers (eg, rifampin, carbamazepine); monitor and adjust doses. May increase intraocular pressure with anticholinergics, antiparkinson agents. Monitor anticoagulants.
A Rogers treatment plan order has an expiration date, after which it will no longer be in effect. Each order will also contain a review date for a hearing at which a Motion to extend the treatment plan order may be presented. This hearing is called the “periodic review”, and it generally takes place annually. As long as the incapacitated person is receiving antipsychotic medication, you will need to keep the Rogers treatment plan order in effect. To have such a review, the guardian/monitor needs to obtain a new “review” affidavit from the treating clinician, and submit a monitor’s report.